Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders
Go back to Lilly to acquire Centessa Pharmaceuticals to advance treatments for sleep-wake disorders| (NASDAQ: CNTA) | Delayed: 40.18 +0.16 (0.40%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $40.02 | 52 Week High | $ | |||
| Open | $40.07 | 52 Week Low | $ | |||
| Day High | $40.18 | P/E | N/A | |||
| Day Low | $39.98 | EPS | $ | |||
| Volume | 3,758,448 | |||||
| Lilly (Eli) & Co. (NYSE: LLY) | Delayed: 1102.08 +3.51 (0.32%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1098.57 | 52 Week High | $88.16 | |||
| Open | $1112.24 | 52 Week Low | $67.88 | |||
| Day High | $1119.45 | P/E | 255.11 | |||
| Day Low | $1093.15 | EPS | $4.32 | |||
| Volume | 3,014,837 | |||||
